Etoposide

“Platinum (cisplatin or carboplatin)+VP-16： Cisplatin for injection 80-100mg/m2, divided into 3 days, the dose depends on tolerability, every 4 weeks as one cycle; carboplatin...” NCT07138001 ↗

“Standard Induction chemotherapy care included: vincristine, doxorubicin, and dexamethasone (VAD) (0.5 mg, 10 mg/m2, and 40 mg, respectively);dexamethasone,...” NCT00577096 ↗

“Control chemotherapy treatment will be chosen from any of the following standard-of-care chemotherapy drugs or combinations: * Carboplatin; * Irinotecan; * Etoposide; *...” NCT03632135 ↗

“The study investigates the tolerance and the efficacy of a new combination of five drugs consisting of propranolol (antiangiogenetic, anti-neuroblastic), Celecoxib (modulating...” NCT02641314 ↗

“Drugs:Chidamide and ICE regimen (ifosfamide, Mesna,Carboplatin and etoposide): Chidamide 20mg on d1,4,8,11;ifosfamide 1.2g/ m2，d1-4,ivg during 4 hours; Mesna 0.4g, 0,4,8 hours...” NCT02856997 ↗

“The purpose of this study is to find out what the response is and the side effects are with chemotherapy using a combination of drugs called D.T. PACE (Dexamethasone,...” NCT00107614 ↗

“Acceptable histology-specific PDC regimens include carboplatin plus paclitaxel or nab-paclitaxel (any histology), carboplatin/cisplatin plus pemetrexed (nonsquamous),...” NCT06865339 ↗

“bleomycin 10 units/m\^2 IV on Day 8 etoposide 200 mg/m\^2 IV on Days 1, 2 and 3 doxorubicin 35 mg/m\^2 IV on Day 1 cyclophosphamide 1250 mg/m\^2 IV on Day 1 vincristine 1.4...” NCT01118026 ↗

“All patients will receive 8 cycles of R-CHOEP immunochemotherapy every two weeks with the following doses per cycle: rituximab 375 mg/m², cyclophosphamide 750 mg/m²,...” NCT03399513 ↗

“Patients with a persistently positive interim-PET scan assigned to arm B2 will receive six blocks of the B-ALL protocol (rituximab, methotrexate, ifosfamide, etoposide,...” NCT00554164 ↗

“This is a phase 1/2 open label study to assess the safety and efficacy of pixantrone in combination with bendamustine, etoposide and , for CD20 positive B-cell lymphomas,...” NCT02678299 ↗

“The investigator prospectively evaluated the combination of Rituximab and Dexa-BEAM (dexamethasone, carmustine, etoposide, cytarabine, melphalan) followed by high dose therapy...” NCT02099292 ↗

“Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning...” PMID 39134959 ↗ Aug 2024

“Tucatinib in Combination With Oral Etoposide (VP16) - Trastuzumab in Patients With Metastatic HER2+ Breast Cancer After Progression Under Tucatinib-Capecitabine-Trastuzumab or...” NCT05955170 ↗

“Subjects will receive Nivolumab 360 mg every 3 weeks (Q3W) first day of each cycle plus Carboplatin AUC5 Q3W first day of each cycle plus Etoposide 100 day 1-3 of each cycle up...” NCT03980925 ↗

“Chemotherapy agents may include doxorubicin, ifosfamide, docetaxel, CHOP regimen, etoposide, cyclophosphamide and vincristine which will be administered as per standard of care...” NCT04570423 ↗

“R-ICE:rituximab 375mg/m\^2 before chemotherapy, ifosfamide 5g/m\^2 24 hours continuous infusion (CI) on Day 2+mesna, carboplatin area under the curve (AUC)5 Day 2, maximum dose...” NCT03391466 ↗

“Chemotherapy is based upon regimes with well known effectiveness in Hodgkin lymphoma. (i.e. ABVD: doxorubicin, bleomycin, vinblastine and dacarbazine and ESHAP: Etoposide,...” NCT03500133 ↗

“Patients received a maximum of 2 cycles of the intravenous (IV) 5-drug regimen (clofarabine, etoposide,cyclophosphamide, PEG-asparaginase, and vincristine) plus intrathecal...” NCT00991133 ↗

“Radiotherapy Technique: IMRT Total dose: 50 Gy Per fraction: 2 Gy Chemotherapy: q3w Dexamethasone 40 mg d1-4 Ifosfamide 1200mg/m2 d1-4 Etoposide 60 mg/m2 d1-4 Cisplatin 20mg/m2...” NCT01667302 ↗

“The chemotherapy entails the administration of multiple cycles of infusional doxorubicin, etoposide and vincristine chemotherapy (total of 3), alternating with cycles of...” NCT00001430 ↗

“Six cycles of standard induction chemotherapy consisting of cyclophosphamide, vincristine, doxorubicin (or epirubicin), etoposide, and cisplatin administered according to the...” NCT07688252 ↗

“Topo II inhibitor Etoposide (VP-16) can reduce cell survival, enhance DNA damage, and delay resistance in Osimertinib-resistant cells, suggesting a potential combination...” NCT06436144 ↗

“Induction treatment with: 4 cycle of Vincristine (9mg/,2), Dactinomycin (6mg/m2), Doxorubicin (160mg/m2), Cyclophosphamide (2.4g/m2), Ifosfamide (18g/M2) and Etoposide...” NCT02063022 ↗

“If the postoperatively pathological examination of the patient is confirmed to be in pT1-2N0 stage, a single postoperative adjuvant chemotherapy (combining etoposide with...” NCT03514849 ↗

“Dosing of chemotherapy is etoposide 90mg/m² body surface area (BSA) day 1-3 in combination with cisplatin 75mg/m² BSA on day 1 or carboplatin area under the curve (AUC) 5 mg/ml...” NCT06223711 ↗

“Chemotherapy agents for consolidation include dexamethasone, vincristine, methotrexate, PEG-asparaginase (Erwinia asparaginase when PEG-asparaginase is not available),...” NCT04501614 ↗

“Used drugs are rituximab,cyclophosphamide, prednisone, dexamethasone, vincristine, methotrexate, iphosphamide, teniposide, etoposide, dexamethasone, cytarabine,adriamycin,...” NCT01290120 ↗

“This trial is to evaluate the efficacy of concurrent chemoradiotherapy with cisplatin followed by VIPD (etoposide, ifosfamide, cisplatin, dexamethasone) in localized NK/T-cell...” NCT00418535 ↗

“The other drug must contain one of the following: etoposide, vinorelbine, vinblastine, pemetrexed, taxanes (e.g., paclitaxel, docetaxel, albumin paclitaxel, paclitaxel...” NCT06424899 ↗

“Etoposide is given at a dose of 100 mg/m2 intravenous infusion over a 2 hour period every 12 hours on treatment days -5, -4, -3, and -2, for a total of 8 doses (Day 0 = stem...” NCT00058292 ↗

“Participants on mitoxantrone, etoposide, cytarabine(MEC) will receive 8 mg/m\^2 of mitoxantrone daily by IV for 3 days (day 1 to 3), 100 mg/m2 of etoposide daily by IV for 7...” NCT05876832 ↗

“Rituximab combined with Chemotherapy (Rituximab, Cyclophosphamide, doxorubicin, Vincristine, Prednisone, Ifosfamide, Gemcitabine, cisplatin, Carboplatin, Etoposide, MESNA,...” NCT07187960 ↗

“Patients will be treated with carboplatin or cisplatin with etoposide, paclitaxel, albumin-bound paclitaxel or pemetrexed at the discretion of the treating thoracic medical oncologist.” NCT04905316 ↗

“Other drugs are administered at starting doses (Etoposide 50 mg/m2 (Days 1-4), Doxorubicin 10 mg/m2 (Days 1-4), Vincristine 0,4 mg/m2 (Days 1-4) and Cyclophosphamide 750 mg/m2 (Day 5).” NCT06871007 ↗

“Day 1 of each cycle will consist of an infusion of rituximab followed by the initiation of a 96-hour continuous infusion of etoposide, doxorubicin, and vincristine and oral prednisone.” NCT00799136 ↗

“Etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (EPOCH-R) followed by idiotype vaccine and granulocyte-macrophage colony-stimulating factor (GM-CSF).” NCT00005780 ↗

“Rituximab 375 mg/m2 d0; Lenalidomide 25mg/d d1-10; Ifosfamide 5g/m2 d2; Carboplatin calculate according to AUC=5 (single dose ≤800 mg); Etoposide 100mg/m2 d1-3; Tirelizumab 200mg d6.” NCT05050630 ↗

“Concurrent chemoradiation will be with platinum-based chemotherapy (cisplatin or carboplatin, with etoposide, taxane, or pemetrexed) selected at the treating physician's discretion.” NCT04364048 ↗

“Rituximab (500 mg/m2 IV once)+ Ifosfamide (1500 mg/m2 IV daily over 3 hours)+ Etoposide (60 mg/m2 IV daily over 1 hour), and Cytarabine (2 grams/m2 IV over 3 hours for 4 doses)” NCT00392990 ↗

“High intensity: intermediate or high dose cytarabine (HiDAC); mitoxantrone, etoposide, and cytarabine (MEC); or fludarabine, cytarabine, G-CSF, +/- idarubicin (FLAG/FLAG-Ida).” NCT02920008 ↗

“Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)” NCT03964090 ↗

“Rituximab 375mg/m2 at day 0, Meththylprednisolone 500mg IV at days 1 to 5, Etoposide 40mg/m2 at days 1 to 4, Cisplatin 25mg/m2 at days 1 to 4, Cytarabine 2000mg/m2 at day 5.” NCT01278602 ↗

“IP: cisplatin 50mg/m2 and etoposide 100mg/m2, weekly, 4 times; 14 days later IV: paclitaxel 175mg/m2 plus carboplatin AUC 5 or docetaxel 60-75mg/m2 plus carboplatin AUC 5” NCT01669226 ↗

“Vincristine 1.4 mg/m2 (2 mg cap) IV on Day 1, Doxorubicin 10 mg/m2/day CIVI on Days 1-4, Etoposide 50 mg/m2/day CIVI on Days 1-4, Cyclophosphamide 750 mg/m2 IV on Day 5.” NCT04002947 ↗

“Gemcitabine 1.0 g/m² on day 1, etoposide 60 mg/m² on days 1-3, pegaspargase 2000 IU/m² on day 4, and dexamethasone 40 mg on days 1-4, repeated every 21 days for 1 cycle.” NCT07678229 ↗

“Vincristine, etoposide, carboplatin, and cyclophosphamide have been used in many protocols for brain tumors but the result was very poor in refractory or relapsed cases.” NCT01535183 ↗

“Temozolomide, etoposide, doxil, dexamthasone, ibrutinib (TEDDI) given every 21 days for cycles 2-6 (Arm 1-A); given every 21 days for cycles 1-6 (Arms 1-B, 2, 3 and 4)” NCT02203526 ↗

“Concurrent with standard of care platinum doublet based chemotherapy (cisplatin + etoposide), radiation treatment plan will be delivered in three sequential phases” NCT04952480 ↗

“Intensive chemotherapy Cladribine-cytarabine-etoposide -venetoclax sequential with fludarabine, busulfan and melphalan or fludarabine and total marrow irradiation” NCT05870995 ↗

“Platinum based chemotherapy including cisplatin and etoposide, carboplatin and paclitaxel or cisplatin and pemetrexed (for patients with non-squamous histology).” NCT03663166 ↗

“Clofarabine intravenously 2-hour infusion,dose 40 mg/m2, followed by Etoposide (VP 16)100 mg/m2 i.v. over 2 hours and Cyclophosphamide 440 mg/m2 i.v. over 1 hour” NCT01385891 ↗

“Radiochemotherapy: Cisplatin (75 mg/m² (BSA) D1#) or alternatively Carboplatin (AUC 5 D1) and Etoposide (100 mg/m² (BSA) D1-3) once every 3 weeks for 4-6 cycles” NCT04602533 ↗

“Etoposide will be administered by IV infusion over 60 minutes following carboplatin administration, during the induction phase on Day 1 through 3 of each cycle.” NCT04028050 ↗

“* EA±Mitox regimen: etoposide injection 100 mg/m2, cytarabine injection 100-150 mg/m2, mitoxantrone injection 8 mg/m2 QD IV for 5 consecutive days (Days 1-5).” NCT06387069 ↗

“Ifosfamide (day 1-3: 1.900mg/m² iv), epirubicin (day 1: 75 mg/m² iv), etoposide (day 1-3: 120 mg/m² iv) and G-CSF (day 5 until end of apheresis: 5µg/kg sc)” NCT02288741 ↗

“Each cycle of NICE consists of four doses of hu3F8, five doses of GM-CSF, one dose of carboplatin, and 3 doses each of ifosfamide and etoposide (table 2).” NCT06438614 ↗

“Standard Chemotherapy (which includes cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate, 6-mercaptopurine, etoposide, and cytarabine” NCT03319901 ↗

“This study aimed to investigate the efficacy and safety of Chidamide together with Etoposide and methylprednisolone for hemophagocytic lymphohistiocytosis” NCT05137522 ↗

“Methotrexate 3g/m2, 3-hour infusion Day 1; Etoposide 100mg/m2, Days 4 to 5; Ifosfamide 800 mg/m2, Days 1 to 5; Cytarabine 150 mg/m2, q12h Days 4 to 5;” NCT04881838 ↗

“The 5 chemotherapy drugs used in the Induction part of treatment are vincristine, cisplatin, cyclophosphamide, etoposide and high-dose methotrexate.” NCT02875314 ↗

“Patients take prednisone by mouth on days 1 to 5 and etoposide, doxorubicin, and vincristine as a 96-hour infusion through a vein over days 1 to 5.” NCT00114738 ↗

“first-line chemotherapy must be platinum-based: cisplatin(75mg/m2 for d1) or carboplatin（AUC 5 for d1) combined with etoposide（100mg/m2 for d1-d3）” NCT02772107 ↗

“Dose Adjusted - Etoposide Prednisone Vincristine Cyclophosphamide Doxorubicin - Rituximab (DA-EPOCH-R) and nivolumab are both feasible treatments.” NCT03620578 ↗

“MK-0646 should be given 1st followed within 30-60 minutes by cisplatin and then etoposide for cycles which include both MK-0646 and chemotherapy.” NCT00869752 ↗

“R-HDS : Rituximab supplemented high-dose (Cyclophosphamide,Ara-C, Methotrexate, Etoposide, Cis-Platin) sequential chemotherapy with autografting.” NCT00355199 ↗

“Mitoxantrone hydrochloride liposome, carmostine, etoposide and cytarabine will be used as conditioning regimen for ASCT in the lymphoma patients.” NCT05681403 ↗

“This phase II study aimed to evaluate the efficacy and safety of oral niraparib plus etoposide in platinum resistant/refractory ovarian cancer.” PMID 39074931 ↗ Nov 2024

“Carmustine (B) also known as BCNU Etoposide (E) Cytarabine (A) also known as Ara-C and cytosine arabinoside Melphalan (M) also known as alkeran” NCT00574509 ↗

“platinum-based chemotherapy (carboplatin \[area under the curve (AUC) 5 mg/mL per min, IV\] and etoposide \[100 mg/m2, IV, D1-D3\] for ES-SCLC)” NCT06620796 ↗

“ADE chemotherapy Cytarabine (100mg/m2 d1-d10 BD), Daunorubicin (50mg/m2 d1-d3) and Etoposide (100 mg/m2 d1-5) over a period of 10 days” NCT03053206 ↗

“The recommended chemotherapy is based on the current reference combination of platinum (cisplatin or carboplatin) and etoposide (VP16).” NCT04268121 ↗

“A Phase II Trial of High-dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) in the Up-front Treatment of Multiple Myeloma” NCT02416206 ↗

“Etoposide 50 (50-150) mg/m2 IV daily for 3-5 days every 21 to 28 days OR 100 (50 300) mg/m2 PO daily for 3-5 days every 21 to 28 days” NCT00117598 ↗

“Etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin (EPOCH) plus rituximab and campath every 3 weeks for up to 6 cycles” NCT01030900 ↗

“Etoposide 75mg/m2/iv over 90min through day 1 to day 4 and cisplatin 25mg/m2/iv over 30min through day 1 to day 3, repeat Q 3weeks.” NCT02738723 ↗

“Etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin (EPOCH) + Alemtuzumab (Campath) every 3 weeks for up to 6 cycles.” NCT00069238 ↗

“In course one with cytarabine and etoposide either mitoxantrone (standard) or DaunoXome (experimental) is given as anthracycline.” NCT01828489 ↗

“Bevacizumab 15mg/kg IVF on D1, Etoposide 70 mg/m2 IVF QD, D2-4, Cisplatin 70 mg/m2 IVF on D2, repeat every 3 weeks, for 3 cycles” NCT02185352 ↗

“Cisplatin 50 mg/m2 administered on days 1,8, 29, 36; Etoposide 50 mg/m2 administered on days 1-5 and then again days 29-33” NCT01416961 ↗

“short-course etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin with dose-dense rituximab (SC-EPOCH-RR)” PMID 20130244 ↗ Feb 2010

“Semustine, 300 mg/m2，-6d； Etoposide, 100 mg/m2，-5～-2d； Cytarabine, 100mg/m2，q12h，-5～-2d； Cyclophosphamide, 1.5g/m2，-5～-2d” NCT04880746 ↗

“conventional chemotherapy (cyclophosphamide, doxorubicin, vincristine, etoposide, prednisone) and rituximab (R-CHOEP-14)” PMID 23168367 ↗ Nov 2012

“alternating cyclophosphamide, vincristine and idarubicin alternating with another 3 cycles of carboplatin and etoposide” NCT03475121 ↗

“IVE, ifosfamide 2000 mg/m2 on days 1-3, epirubicin 70 mg/m2 on day 1, and etoposide 100 mg/m2 on days 1-3 every 21 days” PMID 32349779 ↗ Apr 2020

“etoposide (100 mg per square meter of body-surface area, administered intravenously on days 1 through 3 of each cycle)” NCT04487756 ↗

“Etoposide 50mg/m2, ivgtt, d1-d5; cisplatin 50mg/m2, ivgtt, d1 and d8, every 28 days for a cycle, a total of 2 cycles” NCT02215356 ↗

“6 courses of platinum/etoposide/bevacizumab/camrelizumab and a total period of 12 months bevacizumab/camrelizumab” NCT04635956 ↗

“initiation : etoposide 100mg/m2/d i.v. + cyclosporine 2mg/kg i.v. q 12hours + dexamethasone 20mg/m2/d i.v. (D1-3)” NCT01547143 ↗

“serplulimab 300mg, d1, q3w, iv. etoposide 100 mg/m2, d1-3, q3w, iv. carboplatin AUC 5 (up to 750mg), d1, q3w, iv.” NCT05957510 ↗

“Chemotherapy:vincristine,1.5mg/m2;carboplatin,560mg/ m2;etoposide,150 mg/ m2.monthly for the first three months.” NCT05080010 ↗

“The first Peripheral Blood Stem Cell Rescue will consist of Etoposide, Carboplatin, Cyclophosphamide, and Mesna.” NCT00179816 ↗

“3 cycles of lenalidomide 5mg, etoposide, methylprednisolone, cisplatin, cytarabine and rituximab every 3 weeks.” NCT02340936 ↗

“R-DA-EPOCH (rituximab and dose adjusted-etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin)” NCT03023878 ↗

“Carboplatin AUC 5 d1 + Etoposide 100 mg/m² d1-3 + thoracic involved-field radiotherapy (IFRT), q3w × 4 cycles.” NCT07559786 ↗

“Immuno-chemotherapy regimen included etoposide, cisplatin, iparomlimab and tuvonralimab, and thymosin alpha 1.” NCT07103408 ↗

“Chemotherapy:vincristine,1.5mg/m2;carboplatin,560mg/ m2;etoposide,150 mg/ m2.monthly for the first six months” NCT02137928 ↗

“Patients will receive three cycles of atezolizumab in combination with carboplatin/cisplatin plus etoposide.” NCT06768307 ↗

“semustine 250mg/m2 PO d1; etoposide 200mg/m2 IV d2-5; cytarabine 400mg/m2 IV d2-5; melphalan 140mg/m2 IV d6.” NCT05504603 ↗

“R-HDS (cyclophosphamide, cytarabine, and etoposide) supported by autologous stem-cell transplantation (ASCT)” PMID 26282634 ↗ Aug 2015

“Etoposide combined with cisplatin or carboplatin, administered every three weeks for a total of four cycles.” NCT06719700 ↗

“Etoposide: total 100 mg/m2, once a day, continuous intravenous drip for more than 3 hours, days 1 to 3, q3w” NCT05668767 ↗

“dose-adjusted etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, and rituximab (DA-EPOCH-R)” PMID 32453640 ↗ May 2020

“Induction therapy: TQB2450 1200mg, d1+carboplatin (AUC5) , d1+ etoposide 100mg/m2, d1,d2,d3, q3w, 4 cycles.” NCT04539977 ↗

“Etoposide 100 mg/m2/d d 1 - 4 CI Cisplatin 25 mg/m2/d d 1 - 4 CI Ara C l g/m2 d 5 Dexamethasone 40 mg d 1-5” NCT00580372 ↗

“bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPPesc)” NCT01652261 ↗

“infused etoposide, doxorubicin, and cyclophosphamide with vincristine, prednisone, and rituximab (EPOCH-R)” PMID 24224624 ↗ Nov 2013

“ifosfamide 1500 mg/m² iv days 1 - 4, etoposide 125 mg/m² iv days 1 and 4, and adriamycin 50 mg/m² iv day 1” NCT01382030 ↗

“Chemotherapy: Cisplatin (50 mg/m2) on days 1, 8, 29, and 36 and etoposide (50mg/m2) on days 1～5 and 29～33.” NCT03588494 ↗

“ESHAP (etoposide, methylprednisolone, cisplatin, cytosine arabinoside) chemotherapy was invented in 1994.” NCT00930605 ↗

“SHR-1316(Adebrelimab)，20mg/kg,+Cisplatin 75mg/m2, d1+ etoposide 100mg/m2, d1,d2,d3, q3w, iv, 4 cycles.” NCT05496166 ↗

“Etoposide - 100 mg/m\^2 IV over approximately 1 hour each day for 3 days every 21 days for 2-6 cycles.” NCT03264131 ↗

“Etoposide: 80-100mg/m², intravenous infusion, given at week 1, 4, 7, 10, 13, 16, a total of 6 cycles.” NCT06371482 ↗

“Chemotherapy options include carboplatin/ paclitaxel and cisplatin/etoposide per standard of care.” NCT03745222 ↗

“Etoposide will be administered intravenously at a dose of 100 mg/m² on days 1 to 3 of each cycle.” NCT06784206 ↗

“Etoposide: (100 mg/m2) administered intravenously on Days 1, 2, and 3 of each cycle for 4 cycles” NCT04952597 ↗

“One bridging chemotherapy cycle consists of five days of therapy using Carboplatin and etoposide” NCT07291102 ↗

“ETOPOSIDE Dosage: total 900 mg/m2, IV, which is 150 mg/m2 during 12 hours (days +1, +2 and +3).” NCT01361191 ↗

“50 mg/m2 per day as a continuous intravenous infusion from day 1 to day 4 (96 h) for etoposide” PMID 37011643 ↗ Mar 2023

“PD-1 inhibitor (tirelizumab) combined with ifosfamide, carboplatin and etoposide (ICE) regimen” NCT04860674 ↗

“BCNU, etoposide, cytarabine and melphalan (BEAM) chemotherapy are given after 90Y-daclizumab” NCT01468311 ↗

“neoadjuvant chemotherapy is based on the combination of etoposide and cisplatin/carboplatin.” NCT03523234 ↗

“Etoposide, Prednisone, Doxorubicin, Cyclophosphamide, Vincristine, Rituximab, Pegfilgrastim” NCT02142049 ↗

“dose-adjusted etoposide, doxorubicin, and cyclophosphamide with vincristine and prednisone” NCT05996185 ↗

“CE: Carboplatin AUC=8 IV daily days -4 to -2, Etoposide 400mg/m\^2 IV daily days -4 to -2” NCT06418789 ↗

“CYVE Consolidation (2 cycles): Cytarabine, High-Dose Ara-C, Etoposide, Rituximab, G-CSF.” NCT01046825 ↗

“etoposide, methotrexate, actinomycin D/cyclophosphamide, vincristine, alternate weekly” NCT05139095 ↗

“Drug: Etoposide Etoposide (60 mg/ m2) will be administered by an intravenous infusion” NCT06433362 ↗

“Brentuximab Vedotin Etoposide Cyclophosphamide Doxorubicin Dacarbacine Dexamethasone” NCT06919679 ↗

“NOVE-HiDAC consists of mitoxantrone, etoposide, and modified high-dose cytarabine.” NCT01222143 ↗

“Etoposide 100 mg once daily orally d 1-7 + cisplatin 60-75 mg/m2 d1 every 3 weeks.” NCT04055038 ↗

“BeEAC (Bendamustine, Cytarabine, Etoposide, Cyclophosphamide) conditioning regimen” NCT03315520 ↗

“Fludarabine 150mg/m2, busulfan 6.4mg/kg, melphalan 100mg/m2 and etoposide 600mg/m2” NCT04897139 ↗

“followed by high dose chemotherapy with treosulfan, etoposide and cisplatin (TEC)” NCT00384553 ↗

“etoposide: 100mg/m2/d vgtt q12h D-7-D-4 cytarabine: 200mg/m2/d vgtt q12h D-7-D-4” NCT06652165 ↗

“2. PE (Cisplatin 50mg/m2 on days 1,8,29,36 Etoposide 80mg/m2 days 1-3 and 29-31)” NCT01336543 ↗

“vincristine, cyclophosphamide, cisplatin, etoposide with or without methotrexate” NCT06193759 ↗

“Etoposide :50 mg/m(2) per day continuous IV infusion over 24 hours on days 1-4” NCT00520130 ↗

“Etoposide (E), intravenous infusion, 100mg/m2, D1-5, even cycle administration” NCT06699472 ↗

“For cycle 1/4/5/6. Etoposide 100mg/m2, d1-3, q3w; Cisplatin 25mg/m2 d1-3, q3w.” NCT04882033 ↗

“chemotherapy:vincristine,1.5mg/m2;carboplatin,560mg/ m2;etoposide,150 mg/ m2.” NCT01899066 ↗

“rituximab, cyclophosphamide, doxorubicin, etoposide, vincristine, prednisone” NCT03293173 ↗

“Adebrelimab (1200 mg, Day 1) + Etoposide (100 mg/m2, Days 1-3) + Carboplatin” NCT06764368 ↗

“Etoposide (100 mg/m\^2) should be administered intravenously over 60 minutes” NCT04878016 ↗

“vincristine 1.4 mg/m2 day 1 etoposide 100mg/m2 days 1,2,3 Prednison 100 mg” NCT01502982 ↗

“During Cycle 2, participants will receive etoposide and cyclophosphamide.” NCT05326516 ↗

“2 cycles of IV P-ICE (pembrolizumab, ifosfamide, carboplatin, etoposide)” NCT04838652 ↗

“Mitoxantrone 8mg/m2 d1-5, etoposide 100mg/m2 d1-5, cytarabine 1g/m2 d1-5” NCT05657639 ↗

“Etoposide 100mg/m\^2 d1-3+ cisplatin 75mg/m\^2 d1-3 or Carboplatin AUC5” NCT07172412 ↗

“etoposide 100 mg/m² on Days 1-3 of each of the first four 21-day cycles” NCT00403403 ↗

“Etoposide 100 mg/m2 i.v. every 12 hours in 250 ml dextrose 5% solution” NCT01827605 ↗

“6 cycles of CEV chemotherapy (carboplatin, etoposide, and vincristine)” PMID 39432296 ↗ Nov 2024

“Etoposide 200 mg/m2/day intravenously once daily from day -5 to day -2” NCT03187210 ↗

“Etoposide: 50 mg/m2/day, in continuous 24-hour infusion, days 1 to 4.” NCT01066429 ↗

“Polatuzumab Vedotin x 1; Rituximab x 1; Cytarabine x 5; Etoposide x4;” NCT05253495 ↗

“Regimen 1: etoposide 75mg/m2 d1-5 + cisplatin 75 mg/m2 day1/ day1-2.” NCT02883543 ↗

“Etoposide 200 mg/m2 and Cytarabine 400 mg/m2 for 4 days (D-6 to D-3)” NCT02008006 ↗

“Etoposide 50mg/ m2, Epirubicin 15mg/ m2, Vincristine 0.4mg/ m2, d1-4” NCT05164770 ↗

“R-ICE consists of rituximab, etoposide, carboplatin and ifosfamide.” NCT03450343 ↗

“Tislelizumab in Combination With Chemotherapy(etoposide/cisplatin )” NCT06851819 ↗

“Etoposide: 100 mg/m², intravenous infusion, Days 1-3, every 3 weeks” NCT07381543 ↗

“alternating prolonged exposure to topotecan and etoposide (VP-16)” NCT00250094 ↗

“SCLC patients will receive six cycles of cisplatin and etoposide.” NCT02701231 ↗

“etoposide 100mg/m\<2\> IV day 1 and 200mg/m\<2\> orally days 2, 3” NCT00388960 ↗

“Etoposide, 300 mg/m²/d in two daily injections at 12-h intervals” NCT01966913 ↗

“ESHAP (etoposide, methylprednisolone, cytarabine, and cisplatin)” NCT00568815 ↗

“vincristine,1.5mg/m2;carboplatin,560mg/ m2;etoposide,150 mg/ m2” NCT02319486 ↗

“plus etoposide 100 mg/m2 1-3q21- for 4 cycles (Induction Phase)” NCT05623319 ↗

“etoposide, 200 mg/m2 intravenously daily from day -5 to day -2” NCT02278796 ↗

“Drug: Etoposide Etoposide (65 mg/m2) on day 2-4, every 3 weeks” NCT06953739 ↗

“* Etoposide 100 mg/mq, e.v. days 1,2,3 (if ≥70 years 75 mg/mq)” NCT02371161 ↗

“IE: ifosfamide 1.8 g/m2/d d1-3; etoposide 100 mg/m2/d d1-3 Q2w” NCT04824352 ↗

“VECP(Vindesine Sulfate, Etoposide, Carboplatin, Prednisolone)” NCT01173887 ↗

“Either irinotecan or temozolomide or carboplatin or etoposide” NCT05718466 ↗

“Etoposide 100 mg/m² IV infusion over 1 hour on day 1,2 and 3” NCT04325425 ↗

“Belinostat at 400 mg/m\^2/day plus Cisplatin plus Etoposide” NCT06406465 ↗

“VIA: VP-16 (Etoposide),Ifosfamide,Mesna, Cytarabine (ara-C)” NCT01083342 ↗

“50 mg per day of Etoposide orally for 21 consecutive days.” NCT00176605 ↗

“Etoposide 75 mg/m²/d, Day 1-4 Ifosfamide 3 g/m²/d, Day 1-4” NCT03643133 ↗

“Drug: etoposide Given IV Other Names: EPEG VP-16 VP-16-213” NCT05922384 ↗

“Etoposide, IV infusion for 96 hours on days 1, 2, 3, and 4” NCT02700022 ↗

“Chidemide，carmustine, etoposide, cytarabine, and melphalan” NCT05931263 ↗

“etoposide - 100 mg/m\^2 on days 1, 2 and 3 of dosing cycle” NCT00823719 ↗

“etoposide (Day1-3 100mg/m2 for squamous cell lung cancer)” NCT02947113 ↗

“vinca alkaloids, steroids, etoposide or alkylating agents” NCT02013167 ↗

“IV Etoposide 100 mg/m\^2 on Days 1-3 of each 21-day cycle” NCT03212937 ↗

“Etoposide (VP-16) 100 mg/m2 twice a day (Days -5 to -2)” NCT00329030 ↗

“Patients treated with bevacizumab and VP-16 (etoposide)” NCT00613028 ↗

“Etoposide (IV, 200 mg/m2 every 12 h on days -5 and -4)” NCT00336843 ↗

“Oral Etoposide Combined With Anlotinib and Envafolimab” NCT05685550 ↗

“Idarubicin, Etoposide, Cytarabine, ATRA, Pegfilgrastim” NCT00893399 ↗

“Prednisone, Cyclophosphamide, Etoposide, Procarbazine” NCT00151281 ↗

“Etoposide 100mg/m2 D1-3 of each 21-day cycle IV drip;” NCT05760053 ↗

“Chemoimmunotherapy: Etoposide 80-100mg/m2 day 1, 2, 3” NCT06479473 ↗

“Etoposide 100 mg / m² / day for 4 days (J-12 to J-9)” NCT03035422 ↗

“etoposide 100 mg/m² IV D1-3 + carboplatin AUC 5-6 IV” NCT07001995 ↗

“Etoposide (200 mg/m2 once daily i.v. on days -8, -6)” NCT01342237 ↗

“2. etoposide 60mg/m\^2 on day 1-3, intravenous drip;” NCT06314334 ↗

“Etoposide injection: 100mg/m2, IV infusion, day 1\~3” NCT02800447 ↗

“Etoposide 100 mg/m\^2 by vein, Over 1 Hour x 5 Days” NCT00500890 ↗

“1 cycle of Etoposide Cisplatine (EP) chemotherapy.” NCT05529251 ↗

“cytarabine and/or etoposide and/or pegasparaginase” NCT03236857 ↗

“apatinib po； ifosfamide ivgtt ; etoposide ivgtt .” NCT05277480 ↗

“procarbazine, etoposide and prednisone (BEACOPP)” PMID 28601705 ↗ Jun 2017

“Etoposide 100 mg/m²/day for 4 days (J-12 to J-9)” NCT03079089 ↗

“etoposide (100 mg/m²) infusion (1 hr) for 3 days” NCT02172872 ↗

“standard-dose etoposide 80-100 mg/m² on days 1-3” NCT06597513 ↗

“Regimen B :IVAC:ifosfamide,etoposide，cytarabine.” NCT03558412 ↗

“Etoposide 200mg/m2 intravenous infusion, day2-5” NCT06682130 ↗

“Cisplatin, Carboplatin, Flourouracil, Etoposide” NCT01525927 ↗

“Etoposide 150 mg/m2/day iv over 3 hours (d1-4)” NCT00844298 ↗

“Etoposide 100 mg/m2/day IV x 5 days (D1 to D5)” NCT05705687 ↗

“Etoposide 165 mg/m2 IV infusion - days 1, 2, 3” NCT01726374 ↗

“etoposide 200 mg/m2 intravenously on days 1-3” PMID 30658935 ↗ Jan 2019

“plus Etoposide 60mg/m2 OR on Day15 through 19” NCT03576378 ↗

“BEAM (BCNU, Etoposide, Cytarabine, Melphalan)” NCT02858258 ↗

“Etoposide 2 x 100 mg/m², iv, day -6 to day -3” NCT00946374 ↗

“etoposide infusion100 mg/m2/day on day 1 - 3” NCT02684708 ↗

“Etoposide: 100 mg/m² infused over 60 minutes” NCT02265770 ↗

“etoposide 100mg/M2 BID on days -5 through -2” NCT00572013 ↗

“Etoposide-cisplatin-doxorubicin or mitotane” NCT06333314 ↗

“Mitoxantrone - Etoposide - Cytarabine (MEC)” NCT06713837 ↗

“Etoposide 50 mg/m2 D1-5, D29-33,IV infusion” NCT03945227 ↗

“Etoposide 40 mg/m2, Continuous infusion 1-4” NCT00113919 ↗

“topotecan, cyclophosphamide, and etoposide” NCT03042429 ↗

“Etoposide: 50 mg/m2 given CIV from day 1-4” NCT04992377 ↗

“Etoposide 200 mg/m2 from day -5 to day -2” NCT01296256 ↗

“Etoposide: 100 mg/m2 (days 1, 2, 3, 4, 5)” NCT05827549 ↗

“etoposide 100 mg/m2 was administered day1” NCT05315336 ↗

“Etoposide: 100mg/m2/d ivgtt q12h D-7-D-4” NCT06652139 ↗

“etoposide 150 mg/m(2) i.v. Days -5 to -3” PMID 23242601 ↗ Dec 2012

“etoposide 100 mg/m2 on Days 1, 2, and 3)” NCT01453205 ↗

“Drug: Etoposide 4-6 cycles every 3 weeks” NCT04449861 ↗

“Etoposide: 100mg/m2/d ivgtt q12h D-6-D-3” NCT05367856 ↗

“Etoposide: 100mg/m2 IV d1,Q3W ,2 cycles” NCT05904015 ↗

“3. etoposide: 40mg/m2 D1-4, intravenous” NCT04065308 ↗

“Etoposide 100mg/ms iv from day +1 to +3” NCT02223208 ↗

“etoposide IV on day 1 of weeks 3 and 7” NCT00846742 ↗

“Etoposide (E) 125mg/m2/day IV over 1hr” NCT01858922 ↗

“etoposide 100 mg/m2/D IV from D1 to D3” NCT00970385 ↗

“BCNU, Etoposide, Cytarabine, Melphalan” NCT03113162 ↗

“Etoposide, 1.7 mg/kg p.o. qd x 21 days” NCT00042367 ↗

“Etoposide, 100mg/m2 iv, day 2 to day 4” NCT02764281 ↗

“Etoposide, 60mg/m2 IV, day 1 to day 3” NCT02733458 ↗

“Etoposide 150mg/m\^2/d qd IVD d-5\~-2” NCT03629873 ↗

“Etoposide 75 mg/m² D1 to D3, 4 cycles” NCT00930891 ↗

“Etoposide, IV, D15 to D19, 100mg/m²/d” NCT03011528 ↗

“High dose etoposide, Cyclophosphamide” NCT00460421 ↗

“Etoposide 100 mg/m2/day IV 4, 5 days” NCT02842931 ↗

“etoposide 50 mg 2, ivgt, D1-5, 29-33” NCT04182698 ↗

“Etoposide 100 mg/m2/day IV 4, 5 days” NCT03479918 ↗

“Etoposide, 100mg /m², D1-3, IV, Q3W.” NCT07069270 ↗

“Etoposide (100 mg/m² IV on Days 1-3)” NCT06554535 ↗

“Chemotherapy (Carboplatin-Etoposide)” NCT06812260 ↗

“Etoposide \[40 mg/m2/ day IV, D1-4\]” NCT04378647 ↗

“Etoposide: 100 mg/（m2•d），ivgtt，D1-3;” NCT02526823 ↗

“Etoposide: 100mg/m2, IV, D1-D3, Q3W” NCT07357623 ↗

“cisplatin/carboplatin and etoposide” NCT06306560 ↗

“Etoposide: 100 mg/m² IV on Days 1-3” NCT07091305 ↗

“Estramustine, Etoposide, Exemestane” NCT02788201 ↗

“Etoposide 100 mg/m² IV on Days 1-3” NCT07358676 ↗

“Etoposide 50 mg/m2/day CI24h d1-d4” NCT01818908 ↗

“etoposide (50 mg/m2 day1-5, 29-33)” NCT01211002 ↗

“etoposide (100 mg/sqm on days 1-3)” NCT06418087 ↗

“etoposide (VP-16) IV over 4 hours” NCT00550992 ↗

“Etoposide: 100 mg/m2 i.v. day 1-3” NCT00791947 ↗

“Etoposide 100 mg/m² i.v. days 1-5” NCT00151255 ↗

“Daily oral Etoposide (50 mg/m2/d)” NCT01858571 ↗

“Etoposide 100 mg/m²/d i.v. (d1-3)” NCT02531841 ↗

“Etoposide: 100 mg/m2, ivgtt, d1-3” NCT06462105 ↗

“Etoposide 200mg/m2 Day 1 to Day 3” NCT01304849 ↗

“etoposide 100 mg/m2 i.v. d 15-17” NCT00517894 ↗

“etoposide (total dose 450 mg/m2)” NCT04499573 ↗

“etoposide 50mg/m2/d CIV days 1-4” NCT01914718 ↗

“etoposide 100 mg/m 2 days 1 - 3” NCT03154918 ↗

“etoposide 100mg/ m2，VD d2，d3，d4” NCT01933282 ↗

“etoposide, 100mg/m² IV day1\~3” NCT02445404 ↗

“Erlotinib Etoposide Everolimus” NCT02551718 ↗

“Etoposide, 100mg/m2, day 1\~3.” NCT06978153 ↗

“etoposide (100 mg/m2 per day)” PMID 31175001 ↗ Jun 2019

“Vepesid(R), VP-16 (etoposide)” NCT00602667 ↗

“etoposide: 100 mg/m2 days 1-3” NCT01576692 ↗

“Etoposide IV (100 mg/m²) day2” NCT00863460 ↗

“* Etoposide 60 mg/m2 Days 1-4” NCT00577512 ↗

“Etoposide 60mg/m2, ivg. d1-4.” NCT03105596 ↗

“etoposide, 200mg, p.o., d2-d4” NCT06069830 ↗

“etoposide(200mg/ m2.d, d3-d5)” NCT06933394 ↗

“Etoposide (VP-16) (Vepesid®)” NCT02128230 ↗

“Etoposide 100 mg/m2 on D2-4” NCT04066920 ↗

“etoposide 40 mg/m2 days 1-4” NCT00670631 ↗

“Etoposide 100 mg/m2 IV D1-3” NCT05348213 ↗

“Etoposide 40 mg/m2, D1-4” NCT01300156 ↗

“etoposide IV on days 1-3” NCT00433433 ↗

“Etoposide 100 mg/m2 day1” NCT05164978 ↗

“etoposide 40 mg/m2 D1-4” NCT05244642 ↗

“Etoposide 50mg／m２ ,d1-4” NCT04134247 ↗

“etoposide 75 mg/m2 day1” NCT05775705 ↗

“Etoposide 0.1 g，qd，d1-5” NCT06328179 ↗

“etoposide 100 mg/m2 d1” NCT06504030 ↗

“Etoposide 40mg/m2 D1-4” NCT02431403 ↗

“etoposide（100mg/m2）D1” NCT03841136 ↗

“etoposide + platinum” NCT00391586 ↗

“Etoposide (VdPesid)” NCT00856830 ↗

“Etoposide 50mg/ m2” NCT05097443 ↗

“Drug: Etoposide” NCT03206671 ↗

“Drug: etoposide” NCT03533790 ↗

“EPI：etoposide” NCT03201471 ↗

“Etoposide” NCT02665065 ↗

“Etoposide” NCT03793478 ↗

“Etoposide” NCT06667167 ↗

“Etoposide” NCT01468740 ↗

“Etoposide” NCT03837873 ↗

“Etoposide” NCT00592111 ↗

“Etoposide” NCT00734877 ↗

“Etoposide” NCT01873807 ↗

“Etoposide” NCT01703910 ↗

NCT01783535 ↗

NCT04745689 ↗

NCT00726986 ↗

NCT00513162 ↗

NCT00513474 ↗

NCT00627354 ↗

NCT06769126 ↗

NCT00005834 ↗

NCT00512252 ↗

NCT02949895 ↗

NCT06256237 ↗

NCT02208583 ↗

NCT00005823 ↗

NCT01222572 ↗

NCT05192889 ↗

NCT02521493 ↗

NCT00135135 ↗

NCT00005803 ↗

NCT05863845 ↗

NCT00005802 ↗

NCT07227584 ↗

NCT00005793 ↗

NCT00092222 ↗

NCT07227597 ↗

NCT03719105 ↗

NCT00005863 ↗

NCT02912702 ↗

NCT00678327 ↗

NCT02949258 ↗

NCT07224100 ↗

NCT01300793 ↗

NCT06377540 ↗

NCT04923776 ↗

NCT00136084 ↗

NCT04924101 ↗

NCT00776698 ↗

NCT00416598 ↗

NCT00416676 ↗

NCT06911606 ↗

NCT02101853 ↗

NCT05652686 ↗

NCT00005867 ↗

NCT03792815 ↗

NCT00416832 ↗

NCT06820957 ↗

NCT01481272 ↗

NCT00204646 ↗

NCT07061535 ↗

NCT06125041 ↗

NCT00005631 ↗

NCT04322318 ↗

NCT05903092 ↗

NCT00417053 ↗

NCT00005613 ↗

NCT00033696 ↗

NCT00417248 ↗

NCT04804007 ↗

NCT00005612 ↗

NCT01900509 ↗

NCT04061772 ↗

NCT00514540 ↗

NCT00134030 ↗

NCT00920153 ↗

NCT03669783 ↗

NCT06536868 ↗

NCT00137111 ↗

NCT00776373 ↗

NCT02015728 ↗

NCT00005589 ↗

NCT03467256 ↗

NCT03467360 ↗

NCT07349225 ↗

NCT00003190 ↗

NCT06769971 ↗

NCT05124951 ↗

NCT01516567 ↗

NCT01154439 ↗

NCT04917250 ↗

NCT04803201 ↗

NCT01342887 ↗

NCT05403723 ↗

NCT00515138 ↗

NCT03901118 ↗

NCT00005578 ↗

NCT04326439 ↗

NCT00630565 ↗

NCT00137995 ↗

NCT06164327 ↗

NCT04585893 ↗

NCT04740021 ↗

NCT02836639 ↗

NCT01390584 ↗

NCT00005090 ↗

NCT00057811 ↗

NCT05058755 ↗

NCT00202800 ↗

NCT04063163 ↗

NCT00505921 ↗

NCT00057837 ↗

NCT02899728 ↗

NCT05832320 ↗

NCT00005946 ↗

NCT05309629 ↗

NCT01165112 ↗

NCT00967369 ↗

NCT02773732 ↗

NCT05058651 ↗

NCT00515554 ↗

NCT07625644 ↗

NCT02561273 ↗

NCT00504751 ↗

NCT00054665 ↗

NCT04933617 ↗

NCT02595424 ↗

NCT04189094 ↗

NCT01563601 ↗

NCT00002461 ↗

NCT04189952 ↗

NCT02099188 ↗

NCT02099175 ↗

NCT00601718 ↗

NCT03077828 ↗